Health Sciences Fund is a registered fund series of John Hancock Funds II (series S000034046). Net assets $94.5M as of 2025-02-28.
Showing 15 of 169 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly and Company | — | $10.6M | 1119.36% |
| Intuitive Surgical Inc. | — | $5.9M | 623.87% |
| UnitedHealth Group Incorporated | — | $5.2M | 547.79% |
| Thermo Fisher Scientific Inc. | — | $4.5M | 470.79% |
| Stryker Corporation | — | $4.2M | 444.84% |
| argenx SE | — | $3.5M | 368.29% |
| Vertex Pharmaceuticals Incorporated | — | $3.0M | 317.39% |
| Boston Scientific Corporation | — | $3.0M | 313.66% |
| Danaher Corporation | — | $2.7M | 286.79% |
| Alnylam Pharmaceuticals Inc. | — | $2.3M | 243.58% |
| AstraZeneca PLC | — | $2.2M | 230.60% |
| Elevance Health Inc. | — | $1.7M | 184.87% |
| Regeneron Pharmaceuticals Inc. | — | $1.6M | 168.54% |
| Insmed Incorporated | — | $1.6M | 164.78% |
| BeiGene Ltd. | — | $1.5M | 162.55% |
| Report date | Net assets |
|---|---|
| 2025-02-28 | $94.5M |
| 2024-11-30 | $227.1M |
| 2024-08-31 | $234.8M |
| 2024-05-31 | $268.1M |
| 2024-02-29 | $270.8M |
| 2023-11-30 | $255.4M |
| 2023-08-31 | $265.4M |
| 2023-05-31 | $304.0M |